2nd World Congress on Bioavailability & Bioequivalence 2011- Pharamaceutical R&D Summit (BABE-2011)

Venue: Renaissance Las Vegas Hotel

Location: Las Vegas, Nevada, United States

Event Date/Time: Jun 06, 2011 End Date/Time: Jun 08, 2011
Registration Date: Mar 25, 2011
Early Registration Date: Mar 25, 2011
Abstract Submission Date: Mar 25, 2011
Paper Submission Date: Mar 25, 2011
Report as Spam

Description

2nd World Congress on Bioavailability & Bioequivalence 2011- Pharamaceutical R&D Summit
Dates: 6-8 June 2011
Venue: Renaissance Las Vegas, USA

Website: http://omicsonline.org/BABE2011/

Operated by: Editors-Journal of Bioequivalence & Bioavailability and Journal of Bioanalysis & Biomedicine

Hosting Organization: OMICS Publishing Group


Currently, we are involved in organizing "2nd Annual World Congress on Bioavailability & Bioequivalence: Pharmaceutical R & D Summit" will be held during 6-8 June 2011 Las Vegas, USA. The main theme of BABE-2011 is to “Analyze Novel Approaches of Bioavailability & Bioequivalence studies". BABE-2011 is a specially designed cluster conference, which covers a wide range of critically important sessions from basic Drug development to Advances in Pharmacokinetics, Bioavailability and Bioequivalence studies.


BABE-2011 organizing committee anticipates over 2000 participants to attend this premier event.

Please submit your abstract by online at:
http://omicsonline.org/biobio2011/abstracts.php
or e-mail to BABE2011@omicsonline.org
or fax to +1-650-618-1414

It is our honor to welcome you to give a speech on your expertise:
(OR)
on any of the following sessions

Track 1: Pharmacokinetics, Bioavailability and Bioequivalence
Track 1-1: Pharmacokinetic Concepts in Drug Development
Track 1-2: An Overview on Bioequivalence: Regulatory Consideration for Generic Drug Products
Track 1-3: BA/BE studies of pharmacokinetic drug interactions
Track 1-4: Bioavailability, Bioequivalence, and Drug Selection
Track 2: Bioavailability and Bioequivalence of Novel Drug Delivery Systems
Track 2-1: Sustained Release Dosage Forms
Track 2-2: Targeted Drug Delivery Systems
Track 2-3: Transdermal Drug Delivery Systems
Track 2-4: Pulmonary Drug Delivery Systems
Track 2-5: Topical Dermatological Drug Products
Track 3: IP, Regulatory Affairs and Outsourcing Alliance
Track 3-1: Clinical Data Harmonization Across Countries
Track 3-2: Regulatory Strategy input to the Product Development Plan
Track 3-3: Outsourcing Considerations for Bioequivalence Studies
Track 3-4: Regulatoy Affairs Outsourcing : Pharmaceutical Industry
Track 4: Pharmacokinetic/Pharmacodynamic Models, Biowaivers and Biosimilars
Track 4-1: Biosimilars and Biowaivers in BA/BE studies
Track 4-2: Statistical Issues in BA/BE
Track 4-3: In Vivo/In Vitro Methods to Determine Bioavailability
Track 4-4: Biosimulation Modeling for various diseases
Track 5: Bioanalytical Methodology Development and Validation Using HPLC and LCMS
Track 5-1: Advances in Mass Spectrometry Methodology Development
Track 5-2: Evaluation of Bioequivalence of Highly Variable Drugs and Drug Products
Track 5-3: Design and Evaluation of BE Studies
Track 5-4: Validation of a Sensitive LC-MS/MS Assay to Quantify the Biomarkers
Track 6: PK/PD and Drug Discovery
Track 6-1: Anticancer, Antiviral Drug Development
Track 6-2: Molecular Drug Targets and Fragment based Drug Design
Track 6-3: Improving ADME/DMPK Profile
Track 6-4: PK/PD and Bioanalysis Outsourcing Alliance
Track 6-5: Road Map to Drug Discovery and Develoment
Track 7: Practical Solutions to Pharmaceutical Bioequivalence / Bioavailability Implementation
Track 7-1: Bioequivalence Strategies in Development-an Industry Perspective
Track 7-2: Comparative Bioavailability Studies for New Drugs (NDA)
Track 7-3: Comparative Bioavailability Generic Drug Products (ANDA): Bioequivalence Studies
Track 7-4: Implementing BA/BE Guidelines and CRO Qualification Criteria
Track 8: Key Factors Impacting the Endpoints for Measuring Bioavailability
Track 8-1: Pharmacokinetics/physicochemistry Perspective
Track 8-2: Impact of Formulation on Bioavailability
Track 8-3: Physiological Determinants of Bioavailability
Track 8-4: Bioavailability studies of orphan drugs in paediatric population
Track 9: BA/BE Study designs, protocols, and issues
Track 9-1: Strategies for the Bioequivalence Assessment
Track 9-2: Implementing Effective Modeling and Simulation Tools to Establish Bioequivalence
Track 9-3: An Overview on Bioequivalence: Regulatory Consideration for Generic Drug Products
Track 9-4: IVIVC in Practice for New Chemical Entities and Generics
Track 10: CNS Drug Development: Principles, Transport Kinetics, Diseases, & Methods
Track 10-1: Translational Medicine Approaches to CNS Drug Discovery
Track 10-2: Modeling of the Relationship Between CNS Target Site Exposure to Pharmacological Endpoints
Track 10-3: Bioequivalance of Topical Dermatological Drug Products
Track 10-4: New Perspectives in Anti-Infective Drugs PK/PD
Track 11: Regulatory and Economical aspects in Bioavailability & Bioequivalence

Why to Attend?
• Opportunity to attend the presentations delivered by Eminent Scientists from all over the world
• Selected contributions will be published in Journal of Bioequivalence & Bioavailability and Journal of Bioanalysis & Biomedicine
• Participation in sessions on specific topics in which the conference is expected to achieve progress
• Global networking: In transferring and exchanging ideas
• Share your excitement in promoting Advances of Biotechnology & Pharmacology in various fields
• Conference brings together Scientific Researchers, Business Entrepreneurs and Pharma, Biotech & Healthcare Industry Developers

BABE-2011 initiated by Editors-Journal of Bioequivalence & Bioavailability and Journal of Bioanalysis & Biomedicine will definitely offer you an unforgettable experience in exploring new opportunities, seeking sustainable growth and fuelling your unmet research and business demands. We also hope you join a group of scientists for the fascinating tour to the beautiful city, Las Vegas.

Registration:
Register online: http://www.omicsonline.org/biobio2011/registration.php
Register offline: http://www.omicsonline.org/biobio2011/pdfs/electronicregistrationform.pdf


With Best Wishes,

Dr. YSR Krishnaiah
Nova Southeastern University, USA

Dr. Huixiao Hong
U.S. Food and Drug Administration, USA

Dr. George Perry
University of Texas, USA

Dr. Fritz Sörgel
IBMP, Germany

Dr. Paul Rösch
University of Bayreuth, Germany

Dr. Srinubabu Gedela
Stanford University School of Medicine, USA

Dr. Mirko Diksic
McGill University, USA

Dr. Sudhakar Akulapalli
Boys Town National Research Hospital, USA

Upcoming OMICS Group Conferences
Conferences in USA
Santa Clara, California
• Biomarkers-2010
• Diabetes-2010

Las Vegas, Nevada
• BABE-2011
• Cancer Science-2011

San Francisco, California
• Clinical Research-2011

Baltimore, Maryland
• Biosensors-2011
• Virology-2011

Philadelphia, Pennsylvania
• Vaccines-2011
• Cell Science-2011

• Nanomedicine-2011

Conferences in Asia
Hyderabad, India
• Proteomics-2011
• Biotechnoolgy-2011



OMICS Publishing Group is the member of/publishing partner of/source content provider to
CrossRef PubMed DOAJ Index Copernicus Scientific Commons EBSCO

This is not a spam message, and has been sent to you because of your eminence in the field. If, however, you do not want to receive any email in future from BABE-2011, then please reply with remove/unsubscribe.

Venue

Renaissance Las Vegas Hotel 3400 Paradise Road, Las Vegas, Nevada 89169-2770 USA · Main (702) 784-5700 · Reservations (800) 750-0980 · Meetings (702)
Las Vegas
Nevada
United States
MORE INFO ON THIS VENUE

Additional Information

Home | Call for Abstracts | Abstract Template | Abstract Submission | Registration 2nd World Congress on Bioavailability & Bioequivalence 2011 Pharmaceutical R&D Summit 6-8 June 2011 Renaissance Las Vegas, USA Dear Dr. , OMICS Publishing Group cordially invites you to attend "2nd Annual World Congress on Bioavailability & Bioequivalence: Pharmaceutical R & D Summit" ,which will be held during 6-8 June 2011 at Las Vegas India anticipating over 2000 participants to attend this premier event. BABE-2011 will serve as a catalyst for the advances in Industrial Biotechnology studies by connecting scientists within and across disciplines at sessions and exhibition held at the venue, that creates an environment conducive to information exchange, generation of new ideas, and acceleration of applications that benefit ongoing Bioavailability & Bioequivalence research. Important Dates OMICS Group Conferences helps you to Listen, Explore, Execute & Succeed in your fields of interest. Submit your abstract and share your thoughts that contribute to new innovations in the BABE 2011. Abstract Submission – 5 Feb2011 Speaker Opportunity – 25 Feb2011 Poster Abstracts – 3 April 2011 Website: http://www.omicsonline.org/BABE2011/ Why to Attend? • Opportunity to attend the presentations delivered by Eminent Scientists from all over the world • Global networking through transferring and exchanging ideas • Share your excitement in promoting Health care, Clinical R & D • Conference brings together Scientific Researchers, Business Entrepreneurs and Pharma, Biotech & Healthcare Industry Developers Special Issues: • We are pleased to inform you that selected abstracts will be published in the respective OMICS Group Journals. • Each abstract will receive a separate Digital Object Identification Number (DOI) provided by CrossRef. • Also, the abstracts will be released as a special issue in the OMICS Group Journal. Register Now!! Two easy ways to register for BABE-2011: • Online Registration • Offline Registration • Phone: +1- 650-268-9744 Phone: +1- 650-353-4497 Exclusive Editorial Board Members Dr. YSR Krishnaiah Nova Southeastern University, USA Dr. Huixiao Hong U.S. Food and Drug Administration, USA Dr. George Perry University of Texas, USA Dr. Fritz Sörgel IBMP, Germany Dr. Paul Rösch University of Bayreuth, Germany Dr. Mirko Diksic McGill University, USA Upcoming Conferences • Biotechnology-2011 Hyderabad, India • Proteomics-2011 Hyderabad, India • BABE-2011 Las Vegas, USA • Clinical Research-2011 San Francisco, USA • Cancer Science-2011 Las Vegas, USA • Virology-2011 Baltimore, USA • Biomarkers-2011 Baltimore, USA • Vaccines-2011 Philadelphia, USA • Cell Science-2011 Philadelphia, USA • Diabetes-2011 Philadelphia, USA OMICS Publishing Group is the member of/publishing partner of/source content provider to CrossRef PubMed DOAJ Index Copernicus Scientific Commons EBSCO Find us on: Facebook | Twitter | Linkedin